VIV, Telefônica Brasil's NYSE-listed ADR, arrives at its Q3 earnings release today with one notable shift from four days ago: short sellers have quietly rebuilt positions after a month of retreat.
Since the previous ORTEX preview published on July 24, short interest has ticked up further — now running at roughly 4.1 million shares, a 7% increase over the past week after falling steeply through most of June and early July. That reversal is worth noting, though context matters: the lending market remains extremely relaxed. Availability runs at 539%, meaning more than five shares sit ready to borrow for every one already lent out. Cost to borrow has climbed sharply — up 47% over the week to 1.43% — but that remains well within general-collateral territory. The stock itself has recovered from last Thursday's dip, gaining 0.6% on Monday to close at $14.11, extending a 4.9% monthly advance. Options positioning is muted: the put/call ratio of 1.53 is fractionally below its 20-day average of 1.55, and the z-score of -1.25 suggests options traders are slightly less defensive than usual heading into the print.
The analyst picture has turned more cautious since the start of the year. Barclays cut its target from $16.50 to $15.50 on July 16, maintaining an Equal-Weight rating — a signal that the Street sees the recent rally as having absorbed some of the upside. Scotiabank moved in the same direction in late May, trimming to $15.40. Both targets still sit above the current price of $14.11, preserving a narrow implied upside. Further out, both UBS and JP Morgan downgraded the stock in March, with UBS going all the way to Sell from Buy — a meaningful negative shift that has not reversed. Goldman Sachs remains the lone bullish voice among the named firms, reiterating Buy last August with a target of $12.60, though that figure now sits below the current price and the note is nearly a year old. The consensus arithmetic points to roughly 10-15% implied upside, but the direction of travel among active analysts has been decidedly downward. Factor scores add a partial counterweight: VIV ranks in the 93rd percentile on dividend score and the 98th on days-to-cover, suggesting income-focused investors still see value and short covering pressure remains structurally low.
Past earnings have been unkind to the stock on a short-horizon basis. The May 2026 print produced a one-day decline of 3.4% and a five-day loss of 6.9%. The May 11 release saw a one-day drop of 5.3% and a five-day loss of 9.7%. Both episodes unfolded against a backdrop of broadly comfortable borrow conditions — much as today — which suggests the volatility was driven by fundamental disappointment rather than short-squeeze dynamics.
Today's print will test whether the stock's month-long recovery can withstand analyst scrutiny on 5G monetisation progress and dividend sustainability — the two pillars that separate the bull and bear cases on this Brazilian telecom ADR.
See the live data behind this article on ORTEX.
Open VIV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
